Combining their expertise in clinical trials support and cellular therapies, BloodCenter of Wisconsin (BCW) and the San Diego Blood Bank (SDBB) have created a strategic partnership to accelerate advancements in research and patient care. Together, BloodCenter of Wisconsin and San Diego Blood Bank will offer Celluvative™ – a portfolio of products and clinical trial services that will include esoteric laboratory testing, blood products for research and manufacturing applications, cell processing, and access to a broad database of diverse donors who have expressed interest in clinical trials.
“Through the strength of our partnership, we are able to offer end-to-end services to academic organizations, research institutions and other industry partners who are working to develop novel cellular therapy approaches,” said Matthew Anderson, M.D., Ph.D., medical director, BloodCenter of Wisconsin Diagnostic Laboratories. “Among other offerings, our Celluvative portfolio enables access to an extremely diverse donor database – an invaluable resource to enable advances in the area of regenerative medicine and drug discovery.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7855451-bloodcenter-sdbb-celluvative/
WebMD and Scripps Translational Science Institute (STSI) today announced a new investigative study designed to improve researchers’ and health care professionals’ understanding of what contributes to healthy pregnancies and positive pregnancy outcomes. The Healthy Pregnancy Study will use WebMD’s newly redesigned and enhanced Pregnancy app for iPhone. Incorporation of the Apple ResearchKit software framework will enable survey participants to eConsent, easily and anonymously answer questions, and share connected device data about their pregnancies with researchers for analysis.
“Pregnant women are one of the least studied populations in medical research,” said Dr. Eric Topol, director of STSI and editor-in-chief of Medscape. “The results of our Healthy Pregnancy Study -- on the foundation of an exceptionally popular smartphone app -- will ultimately provide expectant mothers, researchers, and health care professionals with new medical insights to avoid complications during pregnancy.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7579757-webmd-stsi-healthy-pregnancy-study-app/
Today, the American Immigration Lawyers Association (AILA) issued a report card on President Obama's immigration efforts over the past seven years and made recommendations for how to reform immigration in his last year.
“In recent days and weeks he has shown leadership in protecting refugees from Syria,” said AILA President Victor Nieblas Pradis. “But until recently, the president's response was timid and he still plans to resettle only 10,000 Syrian refugees this year. He can save many more lives by setting his target at 100,000 Syrian refugees.”
“In our own hemisphere, when Central American individuals and families, including young children, arrived at our southern border seeking refuge from the horrific violence plaguing those countries, the president should have protected them, but instead, he treated them as a border threat. The president should acknowledge that the situation in Central America is a humanitarian crisis and use every tool at his disposal to protect those fleeing. Most important he should stop detaining thousands of families.”
“The reforms to the legal immigration system he promised a year ago have moved forward at a glacial pace, earning him an incomplete. He can benefit the economy enormously by implementing plans to encourage research, development and entrepreneurial start-ups.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7683151-aila-national-immigration-report-card/
Blood cancers are the third leading cause of cancer deaths in the U.S. However, many Americans are unaware of the impact of these cancers, including leukemia, lymphoma and myeloma, which affect the bone marrow, the blood cells, the lymph nodes and other parts of the lymphatic system.
A new survey commissioned by The Leukemia & Lymphoma Society (LLS) reveals more than four in five adults (82%) are surprised that blood cancers are the third leading cancer killer of Americans. Further, nearly four in five adults (78%) are surprised that acute lymphocytic leukemia (ALL) is the most common cancer in children and young adults under age 20.
To view the multimedia release go to:
https://www.multivu.com/players/English/8128551-lls-blood-cancer-awareness-month/
Federally funded research continues to spur progress against cancer; however, accelerating the pace of progress will require robust, sustained, and predictable annual funding increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Food and Drug Administration (FDA). Additionally, strong financial support for the National Cancer Moonshot Initiative is required, according to the sixth annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
One of the most exciting new approaches to cancer treatment is cancer immunotherapy. As detailed in the report, the utility of immunotherapy is expanding rapidly. For example, on Aug. 1, 2015, one class of immunotherapeutics, checkpoint inhibitors, was initially approved for just two types of cancer—melanoma and lung cancer. As of Sept. 1, 2016, checkpoint inhibitors have been approved for treating six types of cancer—bladder cancer, head and neck cancer, Hodgkin lymphoma, kidney cancer, lung cancer, and melanoma.
To view the multimedia release go to:
http://www.multivu.com/players/English/7911951-aacr-2016-cancer-progress-report/
A new crash test program from the Insurance Institute for Highway Safety aims to ensure that manufacturers pay attention to the safety of front passengers as well as drivers.
The test was developed after it became clear that some manufacturers were giving short shrift to the right side of the vehicle when it comes to small overlap front crash protection. A good or acceptable passenger-side rating will be required to qualify for the Institute’s 2018 TOP SAFETY PICK+ award.
The first test group in the passenger-side small overlap front test program did better overall than vehicles IIHS previously evaluated for research. Ten out of 13 midsize cars tested earn a good rating, while one is acceptable and two earn a marginal rating.
In contrast with a group of 2014-16 model small SUVs tested for research, none of the 2017-18 midsize cars had a poor or marginal structural rating. Instead, the biggest problem in the new group was inconsistent airbag protection in five cars, which would put passengers’ heads at risk.
Today, VSP Vision Care, the largest not-for-profit vision benefits provider in the United States, and market research agency YouGov released new findings showing that half of people in the U.S. are neglecting their eyes despite 84 percent of people rating vision as their most important sense. This disconnect occurs because people don’t understand the importance of annual eye exams and its connection to overall health.
In fact, only 1 percent of people know that signs of serious conditions like thyroid disease, high blood pressure, autoimmune disorders and certain types of cancer can be detected through annual eye exams. This is concerning because even if you have naturally good vision and don’t need prescription glasses, you still need an annual eye exam to protect your overall health.
To view the multimedia release go to:
https://www.multivu.com/players/English/8363551-vsp-vision-care/
While January 1 is the traditional day millions announce their New Year’s Resolutions, research shows only 8% of Americans achieve success. For the fifth year, Life Time, is aiming to help people rethink resolutions and instead make a true, internal commitment to themselves to living a healthy way of life by participating in the Commitment Day 5K Fun Run and Walk. Held at more than 40 Life Time destinations across the U.S. and Canada, Commitment Day empowers individuals, families and communities to start the year on the right foot by marking their pledge with action toward a year of better health. New for 2017, a Virtual 5K is available for anyone in North America to join in. All participants will receive a race bib and commemorative Commitment Day tee shirt. Registration, locations and pricing details are available at www.CommitmentDay.com.
Commitment Weekend kicks off on Friday, Dec. 30 and continues through Monday, Jan. 2, when Life Time will open its doors to everyone – whether a member or not. During each of the four days, Life Time’s 122 destinations will feature a variety of health and fitness experiences and activities for all ages. In addition to the 5K Fun Run and Walk on Jan. 1, people can take part in unique-to-Life Time group fitness, indoor cycle and yoga classes such as Strike, Amp Cycle and Warrior Sculpt, as well as Alpha Training. Life Time’s indoor aquatic centers, basketball courts, rock walls and tennis, racquetball and squash courts will all be open with club-specific programming to help men, women and kids make their commitment even easier by doing activities they love or trying new things that will inspire them in the coming year.
To view the multimedia release go to:
http://www.multivu.com/players/English/7991951-life-time-commitment-day-virtual-5k-fun-run-walk/
Nestlé Purina, a global leader in pet care, hosted its fourth annual Better with Pets Summit at the Brooklyn Expo Center in New York City on Tuesday, October 18, bringing together pet community experts and leaders across the nation to explore how pets and people are living bigger and better lives thanks to new research and innovation that will shape the future of pet care.
Featuring three interactive panel discussions, the Better with Pets Summit examined topics that continue to affect pet care and wellness including the evolving role of pets and their impact on people’s well-being, nutritional innovation that will allow pets to live healthier lives, and demystifying pet nutrition quality and safety standards.
To view the multimedia release go to:
http://www.multivu.com/players/English/7923051-purina-better-with-pets-2016-summit/
Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated.
To view the multimedia release go to:
https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
Weill Cornell Medical College today opened the Belfer Research Building, a state-of-the-art facility that ushers in a new era at the institution for cutting-edge, translational science. The 18-story, $650 million building, made possible through the generosity of numerous donors, nearly doubles Weill Cornell’s existing research space and empowers scientists to rapidly translate groundbreaking discoveries into the most advanced patient care.
To view Multimedia News Release, go to http://www.multivu.com/mnr/65415-weill-cornell-medical-college-belfer-cancer-research-building-opening
Today, WebMD released The Cutting Edge of Cancer a five-part investigative video series developed in partnership with Robin Roberts and her independent production company, Rock’n Robin Productions. Through compelling patient stories and insights from medical experts, The Cutting Edge of Cancer, supported by Cancer Treatment Centers of America®, highlights some of the most promising areas of medical innovation in cancer care, including early detection, immunotherapy, genomic research, and integrative medicine.
To view the multimedia release go to:
http://www.multivu.com/players/English/7579755-webmd-robin-roberts-cutting-edge-of-cancer/
